- Thesis
- Investors worry that cheap AI tools will let rivals copy Constellation's niche, industry-specific software. This fear grew afterwhen organic growth slowed to 3% in the second quarter of 2026, the softest paceor 1% after currency effects. Organic growth of maintenance and recurring revenue fell to 2% after currency effects, its lowest rate in almost sixat least two years. Founder Mark Leonard also resigned as President for health reasons in 2025 and left the board in May 2026. Constellation's software runs core, regulated tasks such as utility billing or court case management. Customers rarely remove this kind of system, since a failure would disrupt daily operations. This makes a quick AI clone unlikely to displace it. But the new CEOPresident, Mark Miller, has not yet run the company's acquisition process through a full economic cycle without Leonard. S&P raised its outlook on Constellation in August 2026 because leverage fell, pointing to falling debt. That is a small signso the balance sheet is not the market's main worry. The clearerfirst test is whether organic growth recovers from its 3of recurring revenue returns to about 5% low, the rate Miller calls normal. It also mattersManagement said that $17 million of one-time revenue at Altera in the second quarter of 2025 caused most of the slowdown. The second test is whether Miller keeps finding acquisitions at good pricesthe same hurdle rates while competition for targets stays intensestrong. Q3 2026 results, expected in early November 2026, give the next organic-growth reading. But proving the capital-allocation approach works without Leonard is a multi-year question, not a one-quarter onetakes several years of results. So this discount likely takes several years to close fully.
- Risks
- Founder Mark Leonard resigned as President for health reasons in September 2025 and left the board in May 2026. Constellation's decentralized model depended heavily on his capital-allocation judgment. It is not yet proven under the new CEOPresident, Mark Miller, over a full cycle.
Organic growth fell to 3% in Q2 2026, its weakest paceor 1% after currency effects. Management named a one-time item at Altera in nearly six yearsQ2 2025 as the main cause, due to large-contract lossesplus weak results at Dark Matter and Lumine and the loss of one large customer attrition in some operating groups. If growth does not recover, the compounding math behind the stock weakens.
Competition for acquisition targets remains intensestays strong. On the Q2 2026 call, and private-market valuationsmanagement said that prices are a little weaker only for larger software assets have not come downthe largest targets. If Constellation cannot keep buying enough companies at attractive prices, it must deploy more cash into lower-return uses, which slows long-term compounding.
- Balance sheet
- Cash: $2.9B
Debt: $4.2B
Net debt: $1.3B
Net debt / EBITDA: 1.1× (low)
Undrawn credit line: $1.1B
Ratings: S&P BBB (positive outlook), Fitch BBB+ (stable outlook)
Constellation reports in US dollars and splits its debt into two groups. The parent must repay the first group, and the. The second group sits inside acquired subsidiaries, mainly Topicus, Lumine and Optimal Blue, without recourse to the parent. At June 30, 2026, $1.5 billion of debt had recourse to the parent. This was $1.0 billion of unsecured senior notes due 2029 and 2034, $348 million (principal) of subordinated floating-rate debentures and an $86 million term loan. The other $2.7 billion had no recourse, mostly floating-rate. Topicus had $534 million of it and Lumine $482 million. Most of the rest is bank loans of other operating groups, secured on subsidiarytheir assets. ThisIt also includes a $500 million 7% promissory note to Intercontinental Exchange thatfrom the Optimal Blue purchase, which matures in 2063. The leverage ratio is S&P's figure for the 12 months to June 2026, and the undrawn. The credit facility is the parent's $1,085 million unsecured facility, with nothing drawn and $13 million of letters of credit. The IRGA liability of $1.2 billion is also like debt. It is the value of the 29.38% of Topicus Coop that the Joday Group can put back to Constellation. This value moves with Topicus's results and share prices. On August 28, 2026, S&P changed the outlook to positive because leverage fell. Free cash flow available to shareholders was $1,078 million in the first half of 2026. Acquisitions stay the main use of cash, and the low leverage leaves room to buy larger companies with debt.
As of 2026-06-30.
- Checkpoints
- Nov 6, 2026 (estimate): Q3 2026 results: organic growth and acquisition spending. Pending. Watch: Organic growth above the 3% of Q2 in the second half of 2026maintenance and a clear capital plan fromrecurring revenue back near 5% after currency effects (2% in Q2), as Mark Miller passexpects, passes; growth at or below 32% after currency effects or weaker acquisition returns faila lower pace of acquisitions fails.
Mar 2027 (estimate): Full-year 2026 results and first annual letter under Miller. Pending. Watch: Organic growth in the second half of 2026 above the 3% of Q2 and a clear capital-allocation plan from Mark Miller pass; organic growth at or below 3% or weaker returns on acquisitions fail.
- Recent events
- 2026-08-28: S&P raisedaffirmed its outlookBBB rating on Constellation Software and changed the outlook to positive from stable. S&P said net leverage fell to 1.1 times EBITDA for the 12 months to June 2026.
2026-08-12: Constellation held a quarterly conference call. Mark Miller said the company will not give an AI target, citing continued deleveraging (falling debt)an AI revenue line or an AI timeline. He said AI has not yet given a real increase in organic growth, and that hurdle rates for acquisitions do not change.
2026-08-11: Constellation reported Q2 2026 revenue of $3,335 million, up 17% from last year. Organic growth was 3%, or 1% after currency effects. Management said most of the softest rateslowdown came from Altera, which had $17 million of one-time revenue in almost six yearsQ2 2025. Free cash flow available to shareholders was $345 million.
2026-05-15: Mark Leonard left the board at the annual meeting. He did not stand for re-election, as the company said on March 27, 2026. He stays as an advisor for the company's long-term minority stakes in other companies.
2025-09-25: Mark Leonard resigned as President for health reasons and stayed on the board. The board appointed Mark Miller, a 30-year Constellation employee and as President. Miller is the company's Chief Operating Officer, to replace him and kept that role. He has been on the leadership team for over 30 years.